RAMM Pharma (XCNQ:RAMM) FCF Margin %: -157.75% (As of Jan. 2026)


What is RAMM Pharma FCF Margin %?

RAMM Pharma XCNQ:RAMM FCF Margin % is -157.75% as of Jan. 2026. The stock has 4 warning signs investors should review. Among 960 Drug Manufacturers companies, RAMM Pharma ranks worse than 88.75% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. RAMM Pharma's Free Cash Flow for the three months ended in Jan. 2026 was C$-0.34 Mil. RAMM Pharma's Revenue for the three months ended in Jan. 2026 was C$0.21 Mil. Therefore, RAMM Pharma's FCF Margin % for the quarter that ended in Jan. 2026 was -157.75%.

As of today, RAMM Pharma's current FCF Yield % is -95.06%.

The historical rank and industry rank for RAMM Pharma's FCF Margin % or its related term are showing as below:

XCNQ:RAMM' s FCF Margin % Range Over the Past 10 Years
Min: -156.04   Med: -87.55   Max: 20.03
Current: -44.27

During the past 8 years, the highest FCF Margin % of RAMM Pharma was 20.03%. The lowest was -156.04%. And the median was -87.55%.

XCNQ:RAMM's FCF Margin % is ranked worse than
88.75% of 960 companies
in the Drug Manufacturers industry
Industry Median: 2.48 vs XCNQ:RAMM: -44.27

RAMM Pharma FCF Margin % Related Terms

RAMM Pharma FCF Margin % Historical Data

* Premium members only.

The historical data trend for RAMM Pharma's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RAMM Pharma FCF Margin % Chart

RAMM Pharma Annual Data
Trend Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
FCF Margin %
Get a 7-Day Free Trial -103.52 -156.04 -86.87 -93.16 -31.54

RAMM Pharma Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -28.32 -55.22 -27.07 -13.86 -157.75

XCNQ:RAMM vs ZTS, UTHR: FCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, RAMM Pharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RAMM Pharma FCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, RAMM Pharma's FCF Margin % distribution charts can be found below:

* The bar in red indicates where RAMM Pharma's FCF Margin % falls into.


RAMM Pharma FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

RAMM Pharma's FCF Margin for the fiscal year that ended in Oct. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Oct. 2025 )/Revenue (A: Oct. 2025 )
=-1.06/3.361
=-31.54 %

RAMM Pharma's FCF Margin for the quarter that ended in Jan. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Jan. 2026 )/Revenue (Q: Jan. 2026 )
=-0.336/0.213
=-157.75 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -157.75% mean?
RAMM Pharma (XCNQ:RAMM) has a FCF Margin % of -157.75% as of Jan. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on RAMM Pharma and its competitors. According to the industry distribution chart, RAMM Pharma ranks #852 out of 960 companies in the Drug Manufacturers industry, placing it in the top 88.7%.
Is RAMM Pharma's FCF Margin % too high?
RAMM Pharma's current FCF Margin % is -157.75%. Based on the distribution chart, RAMM Pharma ranks #852 out of 960 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does RAMM Pharma's FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, RAMM Pharma ranks #852 out of 960 companies for FCF Margin %. This places RAMM Pharma in the lower half of its industry. The industry median FCF Margin % is 2.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.48, based on 960 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on RAMM Pharma and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. RAMM Pharma's current FCF Margin % is -157.75%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RAMM Pharma stock overvalued right now?
Based on GuruFocus' analysis, RAMM Pharma (XCNQ:RAMM) is currently considered Fairly Valued. The stock's GF Value™ is C$0.01, compared to a current price of C$0.01 — trading right at its estimated fair value. The current FCF Margin % is -157.75%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For RAMM Pharma (XCNQ:RAMM), the current FCF Margin % is -157.75% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RAMM Pharma Business Description

Address 82 Richmond Street E, Toronto, ON, CAN, M5C 1P1
RAMM Pharma Corp is engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. The group generates revenue from the sale of medical devices and consumables, the sale of pharmaceutical products, and sale of cosmetics. Geographically, it derives a majority of its revenue from Uruguay.